Half-dose neostigmine and low dose sugammadex as a reversal agent for vecuronium: a pilot randomized trial

Anaesthesia Critical Care and Pain Medicine · Published 2026-05-01 · DOI 10.1016/j.accpm.2026.101865

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.accpm.2026.101865

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles